Ensemble Therapeutics
Ensemble develops Ensemblins to treat diseases by addressing drug targets that are currently inaccessible with small molecule drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD82—123m (Dealroom.co estimates Nov 2007.)
Cambridge Massachusetts (HQ)
Authorizing premium user...